[HTML][HTML] Disorders of cancer metabolism: The therapeutic potential of cannabinoids

D Sun, X Li, S Nie, J Liu, S Wang - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Abnormal energy metabolism, as one of the important hallmarks of cancer, was induced by
multiple carcinogenic factors and tumor-specific microenvironments. It comprises aerobic …

[HTML][HTML] Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges

M Olivas-Aguirre, L Torres-López, K Villatoro-Gómez… - Pharmaceuticals, 2022 - mdpi.com
Cannabidiol (CBD), a major non-psychotropic component of cannabis, is receiving growing
attention as a potential anticancer agent. CBD suppresses the development of cancer in …

Graphene oxide leads to mitochondrial-dependent apoptosis by activating ROS-p53-mPTP pathway in intestinal cells

W Feng, J Wang, B Li, Y Liu, D Xu, K Cheng… - … International Journal of …, 2022 - Elsevier
Owing to its unique physical and chemical properties, graphene oxide (GO) has a wide
range of applications in biomedical field. However, with the gradual improvement of …

Cyclophilin D: guardian or executioner for tumor cells?

L Zhang, Y Liu, R Zhou, B He, W Wang… - Frontiers in …, 2022 - frontiersin.org
Cyclophilin D (CypD) is a peptide-proline cis-trans isomerase (PPIase) distributed in the
mitochondrial matrix. CypD regulates the opening of the mitochondrial permeability …

[HTML][HTML] Mechanisms of Cell Death Induced by Cannabidiol Against Tumor Cells: A Review of Preclinical Studies

ESA Melo, EA Asevedo, JM Duarte-Almeida, F Nurkolis… - Plants, 2025 - mdpi.com
Commonly known as marijuana or hemp, Cannabis sativa L.(Cannabaceae), contains
numerous active compounds, particularly cannabinoids, which have been extensively …

The mitochondria as an emerging target of self-renewal in T-cell acute lymphoblastic leukemia

MA Al-Hamaly, E Winter, JS Blackburn - Cancer Biology & Therapy, 2025 - Taylor & Francis
Acute lymphocytic leukemia (ALL) is the most common leukemia in children, with the T-cell
subtype (T-ALL) accounting for 15% of those cases. Despite advancements in the treatment …

Identification of potential treatments for acute lymphoblastic Leukemia through integrated genomic network analysis

Z Zazuli, LM Irham, W Adikusuma, NM Sari - Pharmaceuticals, 2022 - mdpi.com
The advancement of high-throughput sequencing and genomic analysis revealed that acute
lymphoblastic leukemia (ALL) is a genetically heterogeneous disease. The abundance of …